Parus Finance (UK)’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.56M | Buy |
63,399
+560
| +0.9% | +$50K | 1.71% | 16 |
|
|
2026
Q1 | $4.51M | Sell |
62,839
-1,310
| -2% | -$101K | 1.35% | 17 |
|
|
2025
Q4 | $5.09M | Hold |
64,149
| – | – | 1.34% | 17 |
|
|
2025
Q3 | $4.84M | Sell |
64,149
-34,290
| -35% | -$2.35M | 1.27% | 16 |
|
|
2025
Q2 | $6.79M | Sell |
98,439
-3,921
| -4% | -$257K | 1.94% | 13 |
|
|
2025
Q1 | $6.93M | Sell |
102,360
-6,170
| -6% | -$369K | 2.37% | 13 |
|
|
2024
Q4 | $4.87M | Sell |
108,530
-2,630
| -2% | -$148K | 1.53% | 18 |
|
|
2024
Q3 | $6.99M | Sell |
111,160
-42,020
| -27% | -$2.45M | 2.25% | 14 |
|
|
2024
Q2 | $9.05M | Buy |
153,180
+1,490
| +1% | +$93.2K | 2.62% | 12 |
|
|
2024
Q1 | $12.1M | Sell |
151,690
-21,485
| -12% | -$1.64M | 4.56% | 10 |
|
|
2023
Q4 | $13.7M | Buy |
173,175
+14,064
| +9% | +$1M | 7.11% | 4 |
|
|
2023
Q3 | $11.1M | Sell |
159,111
-20,007
| -11% | -$1.42M | 6.92% | 5 |
|
|
2023
Q2 | $12.4M | Buy |
179,118
+72,038
| +67% | +$5.13M | 5.13% | 8 |
|
|
2023
Q1 | $7.96M | Buy |
107,080
+3,043
| +3% | +$255K | 4.76% | 6 |
|
|
2022
Q4 | $9.7M | Sell |
104,037
-3,266
| -3% | -$315K | 6.59% | 5 |
|
|
2022
Q3 | $10.2M | Buy |
107,303
+3,923
| +4% | +$388K | 8.89% | 4 |
|
|
2022
Q2 | $9.58M | Buy |
103,380
+2,948
| +3% | +$288K | 5.7% | 6 |
|
|
2022
Q1 | $10.2M | Sell |
100,432
-33,138
| -25% | -$3.48M | 3.63% | 9 |
|
|
2021
Q4 | $13.8M | Sell |
133,570
-11,477
| -8% | -$1.06M | 4.42% | 7 |
|
|
2021
Q3 | $12.3M | Sell |
145,047
-22,789
| -14% | -$1.91M | 3.55% | 9 |
|
|
2021
Q2 | $14M | Buy |
167,836
+564
| +0.3% | +$46.2K | 3.39% | 10 |
|
|
2021
Q1 | $12.6M | Buy |
167,272
+5,442
| +3% | +$396K | 3.45% | 8 |
|
|
2020
Q4 | $11.1M | Buy |
161,830
+3,830
| +2% | +$249K | 3.23% | 12 |
|
|
2020
Q3 | $9.23M | Sell |
158,000
-3,130
| -2% | -$195K | 3.14% | 13 |
|
|
2020
Q2 | $10.5M | Buy |
161,130
+66,410
| +70% | +$4.18M | 4.53% | 8 |
|
|
2020
Q1 | $5.62M | Sell |
94,720
-89,350
| -49% | -$5.96M | 6.26% | 7 |
|
|
2019
Q4 | $13.7M | Buy |
184,070
+8,710
| +5% | +$612K | 6.92% | 5 |
|
|
2019
Q3 | $11.1M | Sell |
175,360
-129,970
| -43% | -$7.7M | 6.97% | 6 |
|
|
2019
Q2 | $16.6M | Sell |
305,330
-92,100
| -23% | -$4.96M | 7.62% | 4 |
|
|
2019
Q1 | $21.4M | Buy |
397,430
+221,820
| +126% | +$13.7M | 6.83% | 6 |
|
|
2018
Q4 | $11.5M | Buy |
+175,610
| New | +$13.1M | 4.92% | 8 |
|
Other funds holding CVS
Parus Finance (UK)'s CVS Position: Q2 2026 in Review
Parus Finance (UK) increased its CVS Health (CVS) stake by 0.89% in Q2 2026, buying an estimated $50K and bringing the position to 63,399 shares worth $6.56M. The position accounts for 1.71% of the portfolio, ranked #16.
Parus Finance (UK) first reported a position in CVS in Q4 2018 and has held it in 31 quarters since. The position peaked at $21.4M in Q1 2019. 2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Parus Finance (UK) held 63,399 shares of CVS Health worth $6.56M as of Q2 2026.
- Parus Finance (UK) bought 560 CVS Health shares in Q2 2026, an estimated $50K.
- CVS Health made up 1.71% of Parus Finance (UK)'s portfolio in Q2 2026, its #16 holding.
- Parus Finance (UK) first reported a position in CVS Health in Q4 2018 and has held it in 31 quarters since.
- Parus Finance (UK)'s CVS Health position peaked at $21.4M in Q1 2019.
- 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Parus Finance (UK)'s 13F filing for Q2 2026, filed 21 Jul 2026.